ReviewCurrent drug targets2025

Targeting the Toll-like Receptor Signaling Pathway in Lung Cancer: Therapeutic Opportunities and Challenges.

Muhammad Usama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.